投稿信息
投稿信息
員@2x.png)
審稿費(fèi)用
暫無(wú)數(shù)據(jù)
版面費(fèi)用
暫無(wú)數(shù)據(jù)
中國(guó)人發(fā)表比例
2023年中國(guó)人文章占該期刊總數(shù)量暫無(wú)數(shù)據(jù) (2022年為100.00%)
自引率
9.6 %
年文章數(shù)
3008
期刊官網(wǎng)
點(diǎn)擊查看
(點(diǎn)擊次數(shù):25936)
投稿鏈接
點(diǎn)擊查看
(點(diǎn)擊次數(shù):9135次)
作者需知
暫無(wú)數(shù)據(jù)
NCBI查詢(xún)
偏重的研究方向
期刊簡(jiǎn)介
稿件收錄要求
稿件收錄要求
Well-established as a major journal in today's rapidly advancing experimental and clinical research, Endocrine should be your first choice for the rapid publication of full length articles devoted to the molecular, cellular, biochemical, and physiological aspects of endocrinology, including both clinical papers relating to significant endocrine phenomena that are appropriately controlled and methodological papers of special interest to workers in this area.
常用鏈接
期刊論壇
|
中國(guó)SCI論文
|
期刊介紹
|
投稿信息
|
雜志官網(wǎng)
|
投稿鏈接
|
作者需知
|
PMC鏈接
|
Pubmed全文檢索
